Company Profile

CHOKSI LABORATORIES LTD.

NSE : NABSE : 526546ISIN CODE : INE493D01013Industry : Hospital & Healthcare ServicesHouse : Private
BSE7.47-0.83 (-10 % )
PREV CLOSE (Rs.) 8.30
OPEN PRICE (Rs.) 8.60
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 4837
TODAY'S LOW / HIGH (Rs.)7.47 8.60
52 WK LOW / HIGH (Rs.) 7.11 12.2
NSE
This Company is not listed in NSE

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.36566
Dividend Yield(%)
TTM EPS (Rs.)
P/E Ratio
Book Value (Rs.)
Face Value (Rs.)
MCap (Rs. in Mn)
Price/Earning (TTM)
Price/Sales (TTM)
Price/Book (MRQ)
PAT Margin (%) -13.80
ROCE (%) -8.27
Incorporation Year : 1993

Management Info :

- Chairman Sunil Choksi - Managing Director

Registered Office :

Address : Survey No 9/1,Near Tulsiyana Industrial Park,Gram Kumerdi,
Indore,
Madhya Pradesh-452010

Phone : 0731 4243850 - 88

Website : www.choksilab.com

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE
NEWS More
18Jan01-18-2021$Choksi Laboratories informs about confirmation certificate Choksi Laboratories informs

Choksi Laboratories has submitted the Confirmation Certificate in the matter of Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, received from Share Transfer Agent Link Intime India, for the quarter ended 31st December, 2020.

The above information is a part of company’s filings submitted to BSE.

Choksi Laboratories has submitted the Confirmation Certificate..
01Jan01-01-2021$Choksi Laboratories informs about closure of trading window Choksi Laboratories informs

Pursuant to clause 4 of Schedule B of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended and the clarification issued by National Stock Exchange of India and BSE dated 2nd April, 2019, Choksi Laboratories has informed that the Trading window for dealing in the shares of the Company shall remain close from 1st January 2021 till 48 hours after the declaration of Un-audited Financial Results for quarter ended on 31st December 2020 for Designated Persons, designated Employees and their Immediate Relatives.

The above information is a part of company’s filings submitted to BSE.

Pursuant to clause 4 of Schedule B of SEBI (Prohibition of Insi..
Financials More
Rs. in Millions
QTR Dec 20 ANNUAL 20
Net Profit-10.79-38.86
Gross Profit -9.98000000000001 -57.15
Operating Profit 8.2399999999999931.7
Net Sales 61.67284.88
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Kovai Medical Center (BSE)
 1134.65 (2.02%)
M.Cap ( in Cr)
1241.56
Shalby (BSE)
 113.10 (7.25%)
M.Cap ( in Cr)
1221.59
Dr Agarwals Eye Hsp (BSE)
 330.00 (1.55%)
M.Cap ( in Cr)
155.10
Dr Lalchandani Labs (BSE)
 15.80 (12.06%)
M.Cap ( in Cr)
6.85
Indraprastha Medical (BSE)
 55.90 (1.73%)
M.Cap ( in Cr)
512.45
Shareholding Pattern More
NON-INSTITUTION 68.52 %
PROMOTERS 31.48 %
MUTUAL FUNDS/UTI 0 %
FI/BANKS/INSURANCE 0 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS
Scheme NameHold(%)
No Data Found
F & O Quotes